chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received 1 dose of Pfizer on 3/25/21 at Pharmacy. Patient received 1 dose of Janssen on 5/12/21. Patient is currently incarcerated in jail. On 5/12/21, patient denied receiving any covid-19 vaccine on  consent form and verbally denied receiving covid-19 vaccine Pfizer in March. Around 1600 on 5/12/21, LPN Jail nurse interviewed patient; patient reported only receiving 1 dose of covid-19 vaccine. Writer received fax of consent form record from Pharmacy to verify vaccine, matching demographic information.  No adverse effects noted by writer. Patient being monitored by LPN.
Administrative error: invalid Moderna lot number written on CDC card, then different invalid Moderna lot number in state vaccine record. Pharmacy is unreachable by phone. Administration site was chaotic.
This is a spontaneous report by a non-contactable physician. This male physician reported on behalf of a patient (age and gender unknown) who received on an unknown date PREVNAR 13 on an unknown site, at single dose. Relevant medical history and concomitant medications were unknown. Vaccines taken within the last four weeks were unknown. Vaccines taken on the same day were unknown. Illness at the time of vaccination was unknown. In Oct2013 the patient experienced rash and pneumonia and mentioned that the rash was full grown. Relevant sibling information was unknown. Relevant lab data was unknown. At the time of the report the clinical outcome of the above mentioned events was unknown. No follow-up attempts possible. No further information expected.
couldn't breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (couldn't breath) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M2DA) for COVID-19 vaccination.     Concurrent medical conditions included COPD (Had for 10 years).   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced DYSPNOEA (couldn't breath). At the time of the report, DYSPNOEA (couldn't breath) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, SARS-CoV-2 test positive: positive (Positive) Positive.         The patient reported she was in the hospital for 5 hours and had no symptoms.  Concomitant product use was not provided by the reporter.  No treatment information was reported.
speech problem/hard time speaking/think for a bit before speak; brain fog; feeling tipsy; anemia; This spontaneous case was reported by a consumer and describes the occurrence of SPEECH DISORDER (speech problem/hard time speaking/think for a bit before speak), FEELING ABNORMAL (brain fog), FEELING DRUNK (feeling tipsy) and ANAEMIA (anemia) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder NOS (Thyroid condition).   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced SPEECH DISORDER (speech problem/hard time speaking/think for a bit before speak), FEELING ABNORMAL (brain fog), FEELING DRUNK (feeling tipsy) and ANAEMIA (anemia). At the time of the report, SPEECH DISORDER (speech problem/hard time speaking/think for a bit before speak), FEELING ABNORMAL (brain fog), FEELING DRUNK (feeling tipsy) and ANAEMIA (anemia) outcome was unknown.            No concomitant medication reported. No treatment information was provided.   Reporter did not allow further contact
Severe headache, exhaustion, aches, diarrhea. Unable to perform normal function. Lost 4 days of work.
Type I diabetes; higher baseline heart rates; Blurry vision; This is a spontaneous report from a contactable consumer (patient). A 44-year-old non-pregnant female patient (43-year-old female at the time of vaccination) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 03Apr2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  The patient previously administered with the first dose of bnt162b2 (lot: not reported (Misplaced/discarded)) via an unspecified route of administration, administered in Arm Right on 13Mar2021 as DOSE 1 single for covid-19 immunisation. The patient also previously took pseudoephedrine and experienced drug hypersensitivity (Allergy_Pseudoephedrine). It was reported that the patient experienced Type I diabetes diagnosis and higher baseline heart rates. Blurry vision took place in May (as reported), diagnosis at the end of June (29Jun2021). The events resulted in Doctor or other healthcare professional office/clinic visit. The treatment includes: Insulin. The outcome of the events was recovered with sequel (also reported as patient recovered: Recovered with lasting effects). The reporter considered the events as non-serious.   The lot number for the vaccine [BNT162B2] was not provided and will be requested during follow up.
Patient was given Quadracel at age 3 years and 7 months with dose being #2 in the series. No adverse reaction was reported.  Reported  to VAERS due to Quadracel is approved for ages 4-6 years for booster dose.
Slept for 11 hrs; Malaise general state of fatigue; Experienced high fatigue/tired; Experienced nasal congestion; Irritation of the throat from the post nasal drip; Lymph glands were a bit swollen; Minor body ache for the first 2-3 days; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Experienced nasal congestion), THROAT IRRITATION (Irritation of the throat from the post nasal drip), SOMNOLENCE (Slept for 11 hrs), VACCINATION COMPLICATION (Malaise general state of fatigue) and LYMPHADENOPATHY (Lymph glands were a bit swollen) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced NASAL CONGESTION (Experienced nasal congestion), THROAT IRRITATION (Irritation of the throat from the post nasal drip), LYMPHADENOPATHY (Lymph glands were a bit swollen) and MYALGIA (Minor body ache for the first 2-3 days). On 02-Feb-2021, the patient experienced VACCINATION COMPLICATION (Malaise general state of fatigue) and FATIGUE (Experienced high fatigue/tired). On 07-Feb-2021, the patient experienced SOMNOLENCE (Slept for 11 hrs). On 31-Jan-2021, MYALGIA (Minor body ache for the first 2-3 days) had resolved. On 07-Feb-2021, SOMNOLENCE (Slept for 11 hrs) had resolved. At the time of the report, NASAL CONGESTION (Experienced nasal congestion), VACCINATION COMPLICATION (Malaise general state of fatigue) and FATIGUE (Experienced high fatigue/tired) had not resolved and THROAT IRRITATION (Irritation of the throat from the post nasal drip) and LYMPHADENOPATHY (Lymph glands were a bit swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment medications were reported.   Reporter did not allow further contact
pain at injection site; rash from injection site down to elbow; swelling at injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INJECTION SITE PAIN (pain at injection site), INJECTION SITE RASH (rash from injection site down to elbow) and INJECTION SITE SWELLING (swelling at injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, CLONIDINE and CARVEDILOL for Hypertension, ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (pain at injection site), INJECTION SITE RASH (rash from injection site down to elbow) and INJECTION SITE SWELLING (swelling at injection site). At the time of the report, INJECTION SITE PAIN (pain at injection site) and INJECTION SITE SWELLING (swelling at injection site) outcome was unknown and INJECTION SITE RASH (rash from injection site down to elbow) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Pt recv vax on 3/10/99; on same day pt exp sore/ red/ lump on arm, headache, sinus &chest congestion, fever, cough
This spontaneous report was received from a pharmacist and refers to a 64 year old female patient with unspecified penicillin allergy. The patient's pertinent medical history was not reported. On 09-JAN-2015 at 14:35, the patient was vaccinated with ZOSTAVAX 0.65 ml, once, subcutaneously in left arm, lot # L028282, expiration date: 28-OCT-2016. Her concomitant therapy included multiple unspecified medications. On 09-JAN-2016, the patient developed bilateral numbness and was unable to move her fingers in both hands. On 09-JAN-2016 at 17:00, the patient sought medical attention- she visited unspecified emergency room, but she was not admitted. The patient received NEURONTIN as a treatment. On 12-JAN-2016, the patient was able to move her fingers and was improving. Laboratory diagnostic studies were not performed. The outcome of the events was reported as recovering. The relatedness between the events and ZOSTAVAX was not provided. Additional information has been requested.
Loss of taste; right kidney pain severe; injection site pain; This is a spontaneous report from a contactable consumer (patient). This 60-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; dose 1) via an unspecified route of administration on 25Jan2021 at 10:00 (at the age of 60-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included chronic back pain, scoliosis, kidney stones, 3 double hernias, venous deficiency, fibromyalgia, 2 torn ligaments right foot, diabetes, and diabetic neuropathy. The patient did not receive any other vaccines within four weeks prior to the vaccine. The patient did not have COVID-19 prior to vaccination. The patient received unspecified concomitant medications. The patient previously took morphine from an unknown date for an unspecified indication and experienced allergy. On 25Jan2021 at 10:15 the patient experienced loss of taste, right kidney pain severe, and injection site pain. The patient was not treated for the events. The outcome of the events was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Seven months after receiving my third dose of the COVID-19 vaccine I tested positive for COVID. Prescribed prednisone.
Pt recvd DTP/HIB 5JUN91 & mom states was fussy & warm following days; 9JUN91 woke up screaming; was pale & would go limp & fall back asleep; p/4 episodes of this in 1 hr mom took pt to hosp ER;examined & blood work & UA done; rxn to vax;
I have hard breath & sleepy always please I need help in Emergency room couldn't find answer; I have hard breath & sleepy always please I need help in Emergency room couldn't find answer; This is a spontaneous report from a contactable consumer (patient). A 34-years-old non pregnant female patient received bnt162b2 (Solution injection; Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 15Apr2021 at 12:00 (at the age of 34-years-old) as dose number unknown, single dose for COVID-19 immunisation. Medical history included food fruit allergy. There were no concomitant medications. Patient did not receive any other vaccines in four weeks. Patient was not diagnosed with covid prior to vaccination. Patient was not tested for covid post vaccination. On 15Apr2021 at 13:00, patient experienced to have hard breath and sleepy always please. Patient stated that she need help in emergency room couldn't find answer. Therapeutic measures were not taken due to the events. The outcome of the events was not recovered  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Mild headache and dehydration from approximately 10 PM on 04/11/21 until approximately 4 PM on 04/12/21
Pain in arm; Headache; This is a spontaneous report from a contactable other healthcare professional, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 01Apr2021 at 15:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Concomitant medications included linum usitatissimum seed oil (FLAXSEED OIL) and multivitamin (MANUFACTURER UNKNOWN) from an unknown date for unknown indication. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced pain in arm and headache. The clinical outcome of the events pain in arm and headache was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
.1cc of Ipol administered instead of Tubersol to a patient intradermally like it was a TB skin test/ no AE; Initial information received on 19-Dec-2019 regarding an unsolicited valid non-serious case received from a nurse.  It was reported that 33 years old male patient received .1cc of Ipol  instead of tubersol intradermally like it was a TB skin test/ no AE (wrong product administered) of vaccine IPV (VERO) [IPOL] and while treated with TUBERCULIN TEST [TUBERSOL].  The patient's past medical history, concomitant therapy, medical treatment(s), vaccination(s) and family history were not provided.   On 19-Dec-2019, the patient received a 0.1 ml of suspect IPV (VERO) lot number not reported via intradermal route in the left forearm.  On 19-Dec-2019, TUBERSOL (TUBERCULIN TEST) 0.1 mL administered intradermally (with an unknown batch number) in place of the accidental Ipol administration.  It was a case of actual medication error due to wrong vaccine administered.   It was unknown whether adverse event was experienced by patient or not.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  The information on the batch number was requested.
Patient started to develop pain later the evening. Was seen in Urgent Care the next day and it was questions if patient suffered SIRVA.
Pt; with L shoulder pain, present for past month, ever since flu shot on 10/12/2021. No s/s infection. exam consistant with rotator cuff tendonitis. Treat Tylenol for pain. topical Voltaren gel and lidocaine gel rom, pt and f/u 1 month
I was told by the pharmacist that people like me who already had COVID (I had it in Nov 2020) may feel adverse effects after the first shot, and he was right.  I had similar side effects as when I had COVID and those were: fatigue, muscle pain, joint pain, chills and fever (102 degrees)
All of the general side effects: migraine, nausea/vomiting, muscle aches, chills, fever, pain at injection site (couldn't raise the arm more than 45 Degress at it's worst).  Treatment:  fluids, Advil, rest Symptoms have persisted for 30 hours.
Possibly an autoimmune disease; Possibly Fatigue; Experiencing exacerbation of pre-existing symptoms; This is a spontaneous report from a contactable consumer via the medical information team. A 65-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient exacerbation of pre-existing symptoms since she had the vaccine first dose. The reporter did not know the details of her pre-existing symptoms but stated that fatigue was included and possibly an autoimmune disease. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
11FEB95 pt devel an elevation in temp; 13FEB95 pt saw pvt MD for inc temp-viral that noc mom stated pt had sz episode 1x; 15FEB95 saw PMD again who dx viral illness OM;
reported swelling at injection site starting 2 to 3 days after vaccine. also redness that traveled down the arm (maybe halfway to elbow). took almost 5 days to mostly resolve.
BRUISING all over-rash; arthritis pains; blood in stools; edema in hands, elbow, arms, legs, off/on on fever until 1MAR93 persisting for 3 weeks now;
started chemo for an unknown reason; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION COMPLICATION (started chemo for an unknown reason) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (started chemo for an unknown reason). At the time of the report, VACCINATION COMPLICATION (started chemo for an unknown reason) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment included Chemotherapy.
Adverse immune response, chronic inflammation, uveitis for 45 days, gluten caused allergic reaction and is now off of my diet, severe asthma and rhinitis for 45 days, now managed with daily preventative medication/inhalers. Insomnia for 20 days after 2nd vaccine. Severe neuropathy in hands/feet for 30 days, less severe as time has passed.
Pt reporting tongue swelling, which also occurred after Pzifer vaccine #1.  She took antihistamine prior to first dose.  Reports she frequently has tongue swelling after her allergy shots as well. Denies any mouth swelling, oral itching, changes in respiration.  Pt appears alert, oriented, no facial swelling, no respiratory distress or no respiratory effort.         Benadryl dispensed by RN Clinical Lead at 1135.  She is now resting in obs chair.        --------------   TIME:1145    Pt reporting swelling of tongue has almost completely resolved.  Denies any mouth swelling, oral itching, changes in respiration       --------------   TIME: 1205   Pt reports tongue swelling has resolved. Denies any mouth swelling, oral itching, changes in respiration.  Will be transported home by husband. ED precautions reviewed.  Will notify PCP.
our arm was a bit sore; This is a spontaneous report from a contactable female consumer reported for herself. A 70-year-old female patient received a dose of BNT162B2 (BNT162B2, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered on unspecified date as unknown, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, after the vaccination, the patient stated there arm was a bit sore. The outcome of the event was unknown.  Information about lot/batch number has been requested.  No follow-up attempts possible. No further information expected.
Janssen Covid 19 Vaccine EUA Fever of 100.7 for 6 hours
Fainted after Tdap, Menactra , Varicella vaccines administered - Vital taken rest, fluids, EKG.
Child given MMR 3/17/10. Presents on 11/16/10 with acutely swollen and tender (L) parotid gland.
Headache; body aches; This is a spontaneous report received from contactable reporter(s) (Physician).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown"; PAIN (non-serious), outcome "unknown", described as "body aches".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
large red welt on arm measures 3 1/2 x 4 1/2-hot to touch, itchy, arm sore-tender & warm to touch-welt raised;
Pain and swelling at the injection site began a couple of hours after injection, first few days so painful couldn't lift arm above 90', hurts to lay on that side or if lifts arm above head. Slowly resolving.
IMZ given 12/12/05 on 12/14/05 developed erythema, swelling, pain around both injection sites bilateral thighs. Started on septra, augmentin, atarax. To be rechecked 12/15/05.